| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $1.63 (Beat by $0.19) |
| EPS GAAP Actual | $1.63 (Beat by $0.19) |
| Revenue Actual | $0.617B |
| Revenue Surprise | Beat by $617M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.11 |
| EPS GAAP Estimate | $1.11 |
| Revenue Estimate | $0.5845B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 3.9 | 17.03 | 3.77807 | 4.07902 | 1 |
| Dec 2026 | 2.81169 | 23.63 | 2.7345 | 2.896 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.5 | 0.45047 | 0.617B | 12.16% | 28.6M |
| FQ1 2025 (Mar 2025) | 0.5 | 0.12333 | 0.426B | 11.27% | 23.57M |
| FQ4 2024 (Dec 2024) | 0.12 | -0.008 | 0B | NAN% | -378.65M |
| FQ3 2024 (Sep 2024) | 1.32 | 1.32 | 0.54B | 2.96% | 540M |
| FQ1 2017 (Mar 2017) | 0 | 0 | 0.2765B | 100% | 276.5M |
| FQ2 2017 (Jun 2017) | 0 | 0 | 0.2765B | 100% | 276.5M |
| FQ2 2024 (Jun 2024) | 1.18 | 1.18 | 0.542B | 3.51% | 542M |
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 0.378B | 2.91% | 378M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.11
Consensus Revenue Estimates
0.5845B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.08 | -- | 0.07859457 | 0.08135342 | 1 |
| FQ3 2027 (Sep 2027) | 1.6 | -- | 1.57189 | 1.62707 | 1 |
| FQ2 2027 (Jun 2027) | 1.63 | -- | 1.60136 | 1.65758 | 1 |
| FQ1 2027 (Mar 2027) | 0.59 | -- | 0.57963 | 0.59998 | 1 |
| FQ4 2026 (Dec 2026) | 0.12 | -- | 0.11884 | 0.12177 | 1 |
| FQ3 2026 (Sep 2026) | 1.41 | -- | 1.39635 | 1.43082 | 1 |
| FQ2 2026 (Jun 2026) | 1.27 | -18.11 | 1.2577 | 1.28876 | 1 |
| FQ1 2026 (Mar 2026) | 0.4 | -25 | 0.39613 | 0.40591 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.71B | -- | 0.7B | 0.72B | 3 |
| FQ3 2027 (Sep 2027) | 0.7B | -- | 0.69B | 0.71B | 3 |
| FQ2 2027 (Jun 2027) | 0.69B | -- | 0.68B | 0.7B | 3 |
| FQ1 2027 (Mar 2027) | 0.68B | -- | 0.67B | 0.69B | 3 |
| FQ4 2026 (Dec 2026) | 0.63B | -- | 0.62B | 0.63B | 1 |
| FQ3 2026 (Sep 2026) | 0.62B | -- | 0.61B | 0.62B | 1 |
| FQ2 2026 (Jun 2026) | 0.61B | -1.73 | 0.6B | 0.61B | 1 |
| FQ1 2026 (Mar 2026) | 0.6B | 28.59 | 0.59B | 0.6B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.04953 | 1.5 | 0.45047 | 30.03% |
| FQ1 2025 (Mar 2025) | 0.37667 | 0.5 | 0.12333 | 24.67% |
| FQ4 2024 (Dec 2024) | 0.128 | 0.12 | -0.008 | -6.67% |
| FQ3 2024 (Sep 2024) | 1.32 | 1.32 | 100% | |
| FQ1 2017 (Mar 2017) | 0 | 0 | NAN% | |
| FQ2 2017 (Jun 2017) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 1.18 | 1.18 | 100% | |
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.59B | $0.62B | $28.6M | 4.64% |
| FQ1 2025 (Mar 2025) | $0.4B | $0.43B | $23.57M | 5.53% |
| FQ4 2024 (Dec 2024) | $0.38B | $0B | $-378.65M | -INF% |
| FQ3 2024 (Sep 2024) | $0B | $0.54B | $540M | 100% |
| FQ1 2017 (Mar 2017) | $0B | $0.28B | $276.5M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $0.28B | $276.5M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.54B | $542M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.38B | $378M | 100% |